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substancesAbstract A stability indicating reversed phase liquid chromatographic (RP-LC) method was devel-
oped for the analysis of fingolimod hydrochloride (FIM) and its related compounds in drug sub-
stance and its dosage form. Separation of seven related compounds and three degradation
products was achieved in a C18 stationary phase with 3 mM tetrabutyl ammonium hydrogen sulfate
in 0.02% orthophosphoric acid and acetonitrile in gradient elution. Aqueous mobile phase compo-
nents and column temperature were optimized through Design of experiments (DoE) for a fixed
gradient program. Major degradation products were identified by LC-MS and degradation path-
way is proposed. The validation results indicated that the method is sensitive in detection, linear,
precise and accurate. The developed method was also demonstrated in UHPLC.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Fingolimod hydrochloride (FIM) is a novel drug approved for
the treatment of multiple sclerosis and for the prophylaxis of
acute rejection after solid organ transplantation (Brinkmann
et al., 2002; Mandala et al., 2002). FIM mechanism of action
is unique as it reduces the number of circulating lymphocytes
by preventing their egress from lymph nodes (Rosen et al.,
2003; Sanna et al., 2006). Analytical methods for FIM and its
metabolites in biological samples were found in the literature
(Lee et al., 2007; Min et al., 2002; Berdyshev et al., 2009;
Salm et al., 2006; Emotte et al., 2012). In all these reported
methods, FIM is quantified only in trace level and there is nogolimod
NH3
OH
OH
Cl
Fingolimod hydrochloride 
NH2
OH
OH
.HCl
Impurity-1  
NH2.HCl
OH
OH
OH
Impurity-2 
NH2.HCl
OH
Impurity-3
NH.HCl
OH
OH
Impurity-4  
N
OH
OH
.HCl
Impurity-5 
NH2.HCl
OH
OH
Impurity-6  
NO2
OH
OH
Impurity-7  
Figure 1 Structure of fingolimod HCl and related compounds.
2 R. Suresh Kumar et al.information on its potential impurities. An assay method for
FIM was reported (Chakravarthy and Sankar, 2005), which
is not a stability indicating method and also not suitable for
related substances estimation. Extensive review of literature
shows that no stability indicating analytical method is available
for this high potent medicine. In this work, we described the
development of a stability indicating HPLCmethod for the first
time, for the quantification of related substances and assay of
FIM in drug substance and in dosage form.
Application of Design of experiments (DoE) for HPLC
method optimization and robustness study is widely found in
the literature (Monks et al., 2012; Aguiar et al., 1997; Suresh
et al., 2012; Wang et al., 2006; Hermann et al., 2002; Biswas
et al., 2009). By performing a planned sequence of experi-
ments, called a design, the effects of factors and interactions
between them on response variations can be established. This
approach helps to identify the optimal conditions easily and
makes the method robust.
In this work, the method development begun with screening
the mobile phase through traditional approach of changing one
factor at a time and optimization was done through DoE.
Method optimizationwas done initiallywith a two level factorial
designwith center points. The factorial design indicated the pres-
ence of significant curvaturewhichmeans the optimal conditions
predicted by the designmaynot be reliable.Hence the designwas
augmented with addition of axial points. Thus, the augmented
design which is essentially a central composite design enabled
us to predict the optimal condition for desired responses.
In most of the literature DoE was applied to optimize the fac-
tors in isocraticmethods (Suresh et al., 2012;Wang et al., 2006) or
taken gradient ramp as one of the factors for method optimiza-
tion (Hermann et al., 2002; Biswas et al., 2009). In this work, a
gradient program was fixed and through DoE, two mobile phase
components and column temperature were optimized for that
gradient program. It is important to verify that, whether the pre-
defined gradient program is also influencing the responses mea-
sured. For this, we have used a retention window (RTW); a
plot of retention time versus responsesmeasured and ensured that
the gradient program is not a hidden factor. In this study,wehave
demonstrated to slice the chromatogram and to modify the gra-
dient program in non-critical region; a way to ensure the quick
elution of highly non-polar impurities. A short run time for assay
analysis (where impurities can be allowed to merge with each
other) was also proposed in this study. The method is validated
as per ICH guidelines (ICHQ2(R1), 2005). FIM sample was sub-
jected to forced degradation and through LC-MS analysis prob-
able structure for major impurities was proposed and justified.
Though objective of this work was to develop a HPLC
method, chromatographic parameters to operate this method
in Ultra high pressure Liquid chromatography (UHPLC) are
also presented for UHPLC users. A systematically developed
robust HPLC method can be easily scaled to UHPLC using
standard formula; which was demonstrated in this study.2. Experiments
2.1. Materials and methods
2.1.1. Chemicals & reagents
FIM and impurities 1–7 (Fig. 1) were synthesized at Dr. Red-
dy’s (Hyderabad, India) and completely characterized usingPlease cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:NMR, Mass and IR spectroscopy. FIM capsules formulated
in Dr. Reddy’s laboratories were used for the study. Tetrabutyl
ammonium hydrogen sulfate (TBAHS) and ortho phosphoric
acid (oPA) (85%) were obtained from MerckKGaA (Darm-
stadt, Germany). Acetonitrile of gradient grade was obtained
from Rankem (New Delhi, India). HPLC grade water was
obtained from Milli-Q water purification system (Millipore,
Milford, MA, USA).for reversed phase liquid chromatographic method development of fingolimod
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Table 1 Mobile phase screening trials – Changing One Single factor at a Time (COST).
Trial Mobile phase A Mobile phase B RT of FIM Tailing factor Imp-3 & 4 resolution
1 10 mM KH2PO4 – pH 3.0 Acetonitrile: water (90:10) 30.2 4 0
2 10 mM TBAHS+ 10 mM oPA (pH 2.2) Acetonitrile: water (90:10) 23.1 0.85 0.5
3 10 mM KH2PO4 + 10 mM TEA pH 3.0 Acetonitrile: water (90:10) 22.5 2.9 0
4 10 mM TBAHS+ 10 mM oPA (pH 2.2) Methanol: water (90:10) 36.5 3.1 0
Table 2 Factors and levels to be studied by DoE.
Factor Unit Low (1) High (+1)
TBAHS mM 1 10
oPA % 0 0.1
Column temperature C 30 65
Reversed phase liquid chromatographic method development of fingolimod hydrochloride 32.1.2. Columns & instruments
The HPLC analytical column used was an X-Bridge C18
(150 mm  4.6 mm, 3.5 l) and the UHPLC column used was
BEH-C18 (50 mm  2.1 mm, 1.7 l). The columns were manu-
factured by Waters (Waters Corporation, Milford, MA, USA).
LC1: Alliance 2695 separation module equipped with PDA
detector (Waters)was used for specificity and development stud-
ies. LC2:Agilent 1200 series equippedwithVWD(Agilent Tech-
nologies, Waldbronn, Germany) was used for validation
parameters.
pH meter: Metrohm 780 (Metrohm AG, Herisaw,
Switzerland).
2.1.3. Software
LC1 and LC2 were monitored with Empower 2 software
(Waters). Design Expert version 8.0.7.1 (Stat-Ease Inc.,Table 3 3A. Full factorial design with center points and responses
Standard run Run order Point type Factor A Factor B Factor C Re
(fo
Im
res
6 1 Factorial 10 0 65 0
11 2 Center 5.5 0.05 47.5 1.1
7 3 Factorial 1 0.1 65 1.3
12 4 Center 5.5 0.05 47.5 1.1
1 5 Factorial 1 0 30 1.0
4 6 Factorial 10 0.1 30 0.5
9 7 Center 5.5 0.05 47.5 1.1
2 8 Factorial 10 0 30 0
3 9 Factorial 1 0.1 30 1.0
5 10 Factorial 1 0 65 1.4
10 11 Center 5.5 0.05 47.5 1.1
8 12 Factorial 10 0.1 65 0.9
3B. Augmented design (CCD) with axial points
15 13 Axial 5.5 0 47.5 0.7
17 14 Axial 5.5 0.05 30 0.8
18 15 Axial 5.5 0.05 65 1.2
14 16 Axial 10 0.05 47.5 0.8
19 17 Center 5.5 0.05 47.5 1.1
20 18 Center 5.5 0.05 47.5 1.1
13 19 Axial 1 0.05 47.5 1.3
16 20 Axial 5.5 0.1 47.5 1.1
Please cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:Minneapolis) was used for experimental designs and
interpretation. Microsoft Excel 2007 was used for analysis of
validation results.
2.1.4. Chromatographic condition (HPLC)
Mobile phase A, 3 mM TBAHS and 0.02% oPA in water;
mobile phase B, acetonitrile: water (9:1, v/v). Flow rate,
1.0 ml/min; column oven temperature, 60 C; injection volume,
10 ll; and wavelength, 218 nm. Diluent for drug substance
preparation is water and acetonitrile (7:3, v/v) and for drug
product is 0.1% HCl in methanol: water (1:1, v/v).
Gradient program for related substances: T/%B: 0/30,
30/50, 35/80, 40/80, 45/100, 50/100. Gradient program for
assay: T/%B: 0/40, 15/60, 15.1/100, 20/100.
A minimum of 10 min re-equilibration time is required
between runs.
Sample concentration for related substances is 1.4 mg/ml
and diluted standard of FIM for external quantification of
related substances is 0.0014 mg/ml. Sample concentration for
assay of FIM is 0.07 mg/ml.
For method validation, the limit for impurities 1–7 was
specified as 0.15% and for unknown impurity the limit was
kept as 0.10%.studied.
sponses Retention time
r method optimization) (for RT-window plot)
p-3 & 4
olution (R1)
Tailing factor
(R2)
FIM & Imp-3
resolution (R3)
FIM Imp-3 Imp-4
0.82 1.82 19.7 20.5 20.7
1 1.62 3.96 21.2 22.6 23.0
8 3.69 2.78 20.2 22.7 23.3
1 1.61 3.94 21.2 22.6 23.0
2 3.21 3.9 24.2 26.7 27.0
4 0.81 2.78 23.6 24.7 24.9
1 1.57 3.91 21.2 22.6 23.0
0.74 1.64 24.4 25.4 25.4
4 3.88 3.6 24.8 27.7 28.0
2 2.94 3.08 19.4 21.5 22.0
1 1.61 3.92 21.2 22.6 23.0
2 1.12 2.96 18.6 19.6 19.9
5 0.98 3.58 22.5 23.7 24.1
1.36 4.47 23.2 24.7 25.0
1 1.72 3.36 18.3 19.7 20.1
0.85 2.84 21.9 22.9 23.2
2 1.62 3.93 21.2 22.6 23.0
2 1.61 3.93 21.2 22.6 23.0
4 3.75 3.16 22.4 25.1 25.6
5 1.8 3.85 21.5 23.0 23.4
for reversed phase liquid chromatographic method development of fingolimod
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Table 4 Regression model & statistical tools.
Responses Regression model Model P-value Adj R2 %CV AP
Augmented design – central composite design
Imp-3 & 4 resolution 1.11–0.39A+ 0.18B+ 0.15C+ 0.19AB  0.18B2  0.13C2 <0.0001 0.94 9.8 27.6
Tailing factor 1.59–1.31A+ 0.26B+ 0.03C  0.13AB+ 0.11AC+ 0.73A2  0.18B2 <0.0001 0.99 6.9 39.0
FIM & Imp-3 resolution 3.88–0.45A+ 0.20B  0.24C+ 0.36AB+ 0.25AC  1.02A2 <0.0001 0.91 6.6 16.4
Factorial design Model P-value Curvature P-value
Imp-3 & 4 resolution 0.90–0.43A+ 0.18B+ 0.14C+ 0.19AB <0.0001 0.0014
Tailing factor 1.97–1.28A+ 0.22B  0.01C  0.13AB+ 0.11AC <0.0001 0.0086
FIM & Imp-3 resolution 3.19–0.52A+ 0.21B  0.16C+ 0.36AB+ 0.25AC <0.0001 <0.0001
Adj – adjusted, CV – coefficient of variation, AP – adequate precision.
4 R. Suresh Kumar et al.2.1.5. Preparation of sample solution for drug product
The sample solution for related substances analysis was pre-
pared from a 30 capsule composite sample. A 25 capsule equiv-
alent mass of the capsule contents was mixed with 10 ml of
diluent. The solution was sonicated for 30 min with intermit-
tent shaking with bath temperature of 20 C. Further the sam-
ple solution was centrifuged at 4000 rpm for 10 min. The
supernatant liquid was used for related substances analysis.
1/20th concentration of related substances preparation was
used for assay analysis.
2.1.6. LC-MS condition
The mobile phase A was kept as 0.1% trifluoro acetic acid. All
other chromatographic conditions are as described in Sec-
tion 2.1.4. Agilent 1100 series liquid chromatograph (Agilent
Technologies, Inc., Santa Clara, CA, USA) coupled with an
Applied Biosystems 4000 Q Trap triple quadruple mass spec-
trometer with Analyst 1.4 software, MDS SCIEX, USA
(Thermo Scientific, Sunnyvale, CA, USA) was used for the
mass identification of the degradation products. The analysis
was performed in positive electro-spray/positive ionization
mode with an ion source voltage of 5000 V and a source tem-
perature of 450 C. GS1 and GS2 were optimized to 30 and
35 psi, respectively. The curtain gas flow was 20 psi.2.2. Validation experiments
2.2.1. Precision
The repeatability of the related substance method was checked
by injecting six individual preparations of FIM spiked with
impurities 1–7 at 100% and 150% of specification level. Per-
centage RSD for the content of each impurity was calculated.
Repeatability of the assay method was checked by injecting six
preparations of FIM at three different concentrations (0.035,
0.07 and 0.105 mg/ml) and calculated % RSD for the content
of FIM. The intermediate precision of the method was also
evaluated using different analyst, on a different day with dif-
ferent make instrument in a laboratory located at different pre-
mise of Dr. Reddy’s.
2.2.2. Limit of detection (LOD) and limit of quantification
(LOQ)
The LOD and LOQ for impurities and FIM were estimated by
signal to noise ratio method (ICH Q2(R1), 2005). Precision
study was also carried at the LOQ level by injecting six individ-Please cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:ual preparations of impurities and FIM and calculating the %
RSD of the area. Accuracy at LOQ level was evaluated in trip-
licate for the impurities by spiking the impurities at the esti-
mated LOQ level.
2.2.3. Linearity
Linearity test solutions for related substance method were pre-
pared by diluting the impurities stock solution and FIM stan-
dard solution to the required concentrations. The solutions
were prepared at six concentration levels from LOQ to 150%
of specification limit for impurities. The calibration curve
was drawn by plotting the peak areas of impurities and FIM
versus its corresponding concentration. Linearity test solutions
for assay were prepared at six concentration levels from 25%
to 150% of assay concentration.
2.2.4. Accuracy
Standard addition and recovery experiments were conducted
to determine accuracy of the related substance method. The
accuracy was calculated by spiking the impurities in placebo
based test solution. The study was carried out in triplicate at
50%, 100% and 150% of the specification level of impurities.
The accuracy of the assay was evaluated in triplicate at three
concentration levels, i.e. 0.035, 0.07 and 0.105 mg/ml in by
spiking the drug substance to placebo based test solution. Pla-
cebo is a mixture of mannitol and magnesium stearate. The %
recovery was calculated against 0.07 mg/ml of FIM reference
standard preparation.3. Results
3.1. Method development
3.1.1. Selection of column & mobile phase pH
Column with C-18 stationary phase, which was reported ear-
lier for FIM (Emotte et al., 2012) was chosen. To keep the
molecule in unionized form, it is essential to keep the pH of
the mobile phase at 2 units above the pKa for bases and 2 units
below the pKa for acids. FIM being a basic substance; to ana-
lyze in unionized form it is essential to maintain the pH above
9.8 (pKa of fingolimod is 7.8). At basic pH, limitation of using
high column temperature and dissolution of silica are obvious
(Kirkland et al., 1995; Classens et al., 1996). Hence, we decided
to go with alternate approach of using an acidic mobile phase
and keeping the basic compound in completely ionized form.for reversed phase liquid chromatographic method development of fingolimod
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Figure 2 Response surface graphs. Each response is plotted at
two temperature, (i) 30 C and (ii) 60 C (method condition). Red
surface on the graph indicates the maximum response. Response
decreases toward blue region. (For interpretation of the references
to color in this figure legend, the reader is referred to the web
version of this article.)
Table 5 Method optimization goals.
Response Desirability Design space
Goal Lower Upper
Imp-3 & 4 resolution
(R1)
Maximize 1 1.2 Not less than
1.0
Tailing factor (R2) Minimize 2.5 3 Not more than
2.5
FIM and Imp3 resolution
(R3)
Maximize 3 3.5 Not less than
3.0
Reversed phase liquid chromatographic method development of fingolimod hydrochloride 5Hydrophobic nature of FIM (logP is 4.178), makes it possible
to analyze in ionized form. Furthermore, the pKa of silanols in
the chosen column (X-bridge) is greater than 8, which infersPlease cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:that the silanols on the silica are fully protonated below pH
6.0. Hence at acidic pHa positively charged basic compound
does not interact strongly with silanols which may result in a
good peak shape. Thus, we decided to operate in acidic pH.
3.1.2. Screening of mobile phase components
To screen the mobile phase components, a moderate polar to
non-polar linear gradient program was fixed on a trial basis
(T: %A/B as 0: 70/30, 60: 30/70). The other conditions
employed for screening the mobile phase were: Flow rate –
1.0 ml/min, column temperature – 25 C, wavelength 218 nm
and injection volume – 10 ll. Impurity spiked solution was
injected in each trial.
Most commonly used simple mobile phases were chosen for
initial screening. To operate in acidic condition widely used
phosphate buffer was chosen. Triethylamine is a well-known
mobile phase additive to reduce the peak tailing of basic mole-
cules (Bian et al., 2012; Ruiz et al., 2006; Reta and Carr, 1999).
In addition to that we have decided to investigate tetrabutyl
ammonium hydrogen sulfate (TBAHS) also. TBAHS helps
in reducing the tailing of basic compound through various
mechanisms and mainly by masking the residual silanol activ-
ity of a C18 stationary phase (Wells and George, 1982). A
combination of TBAHS and oPA was reported for a chro-
matographic separation of basic drug (Fletouris et al., 1996).
To select aqueous phase components and organic modifier,
we decided to use the traditional approach of Changing One
Single (or separate) factor at a Time (COST), while keeping
other factors constant. This approach, is also called as One
Factor at a Time (OFAT) is convenient for a limited number
of predetermined experiments. The outcome of COST is given
in Table 1.
Table 1 shows clearly that, symmetric peak can be achieved
with TBAHS mobile phase (Trial 2). Almost similar result was
obtained with phosphate buffer and Triethylamine mobile
phase. In the trials 1 and 3, separation between imp-3 and 4
was not achieved. Hence trial-2 was repeated with methanol
as organic phase (trial-4). In trial-4, FIM was observed as
asymmetric peak and impurities 3–5 were merged together.
Hence, we decided to work further with TBAHS and oPA as
aqueous mobile phase components and acetonitrile as organic
modifier.
3.1.3. Selection of factors & responses for method optimization
The optimization of the method has been carried out through
DoE. Factors and the levels to be optimized through DoE are
given in Table 2. Rationale for choosing the factors and their
range is discussed below.for reversed phase liquid chromatographic method development of fingolimod
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6 R. Suresh Kumar et al.In trial-2 (Table 1), tailing factor of FIM is below 1.0. The
slight fronting of peak may be an indication of TBAHS more
than the required amount. Hence we decided to study TBAHS
from high (10 mM) to low (1 mM) concentration. TBAHS is
generally used in combination with other phosphate or acetate
buffer (Bielejewska and Gold, 2005). pH of an aqueous solu-
tion of TBAHS (10 mM) with or without oPA (0.1%) is about
2.2. Without combining the phosphate or acetate buffer,
TBAHS alone was used as mobile phase additive for chro-
matographic elution of basic compound (Plum et al., 2003).
Hence, we decided to investigate that whether oPA is really
required to include in mobile phase and it was studied from
zero level.
Beneficial effect of higher column temperature on resolu-
tion of closely eluting peaks has been demonstrated adequately
(Gant et al., 1979; Lestremau et al., 2006). To improve the res-
olution of closely eluting pair Imp-3 and 4, we have decided to
study the higher column temperature. Based on column capac-
ity to withstand higher temperature at acidic pH and LC
instrument capability, it was decided to study to the maximum
of 65 C.
From COST trials it was understood that resolution
between imp-3 and 4 and tailing factor of FIM were critical
tasks to achieve. In addition to that, monitoring the resolution
between FIM and imp-3 is considered important, as they are
closely eluting peaks. Hence, these three responses were chosen
for method optimization.
3.1.4. Execution of DoE
Gradient program, flow rate, injection volume and wavelength
used for COST trials (Section 3.1.2) were adopted for DoE
runs. A full factorial design with center points in 4 replicates
was executed for three factors (Table 3).
Standard run, run order adopted and the measured out-
come (responses) is given in Table 3A. Statistically significantFigure 3 A – Design space (overlay plot of effects): yellow region ind
level. Within design space, desirability plot helps to choose the region a
factors at method condition are shown in the flag. Orthophosphoric
highly desirable. Desirability decreases toward blue region. Desirabilit
responses are at maximum level in the design space. Refer Table 5 for
interpretation of the references to color in this figure legend, the read
Please cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:curvature (P< 0.05) (Table 4) was observed for all three
responses, which suggest that a quadratic model may be a bet-
ter fit. Hence the design was augmented by including six axial
points. Axial points together with the factorial and center
points constitute a central composite design (CCD). Outcome
of the augmented runs is given in Table 3B.
3.1.5. Data interpretation
Classical statistical tools (Suresh et al., 2012) were employed to
validate each model and reported in Table 4. In the present
study, the adjusted R2 was >0.90 which revealed that the
experimental data show a good fit with the polynomial equa-
tions. The adequate precision value greater than 4 is desirable.
In this study, the value was found to be in the range of 16.4–39
and hence the model is significant for the optimization process.
A model can be considered reasonably reproducible if the coef-
ficient of variation (C.V.) is less than 10% and in this study all
the models meet the requirement.
For an experimental design with three factors, the model
including linear, quadratic, and cross terms can be expressed as
Y ¼ b0 þ baAþ bbBþ bcCþ babABþ bacACþ bbcBC
þ baaA2 þ bbbB2 þ bccC2 ð1Þ
where Y is the response to be modeled, b is the regression coef-
ficient and A, B and C represent factors. Insignificant terms
(P> 0.05) are eliminated and the reduced models for factorial
design and CCD are given in Table 4.
The magnitudes of the coefficients in the regression equa-
tion (Table 4) were used as the basis for judging statistical sig-
nificance and illustrating the relative effects of linear, quadratic
and cross product interactions between the parameters. By
using regression equations and the response surface graphs
(Fig. 2), conclusions were drawn as follows: (1) Resolution
between imp-3 and 4 (R1), which was the critical task toicates design space. In gray region, responses are below the desired
t which desired responses are at maximum level. The responses and
acid (F(B)) is kept as 0.02%. B – Desirability plot. Red region is
y plot can be used as a tool to choose the region at which desired
criteria and target set for design space and desirability plot. (For
er is referred to the web version of this article.)
for reversed phase liquid chromatographic method development of fingolimod
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Figure 4 Retention window; a plot of responses versus retention time. No correlation between retention time and response is observed in
this scatter plot.
Reversed phase liquid chromatographic method development of fingolimod hydrochloride 7achieve, increases with increase in column temperature.
TBAHS concentration should be kept low to improve the
R1. Phosphoric acid has positive effect on R1. Hence it should
be included in the mobile phase. (2) USP tailing factor (R2)
decreases with increase in TBAHS concentration and column
temperature has no effect on peak tailing. Inclusion of oPA
will increase the R2. Hence concentration of oPA should be
limited in the mobile phase. (3) Low TBAHS is preferred for
improved resolution between FIM and Imp-3. Increase in col-
umn temperature may decrease the resolution.
3.1.6. Fixing the responses for method optimization
Minimum tailing and maximum resolution are desired for a
chromatographic method. To optimize the method lower and
upper values of the responses are defined and given in Table 5.
Rationale for fixing the responses is discussed below:Please cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:In our experience, a method with resolution between two
low level impurities as 1.0 (United States Pharmacopeia,
2011) is good enough for accurate quantification. Hence lower
limit kept for resolution between imp-3 and 4 was 1.0.
From Section 3.1.5 it was understood that TBAHS concen-
tration should be kept low to increase the resolution responses
(R1 & R3). At low TBAHS concentration tailing factor of
FIM would be high. Achieving resolution between the imp-3
and 4 is more important than a perfect symmetrical peak
and if tailing factor is high, external quantification method
can be adopted for accurate quantification. Hence, an argu-
ably accepted limit for tailing factor was kept.
While proceeding with high tailing factor, quantification of
a small impurity (imp-3) which elutes immediately after a big
asymmetric peak (FIM) will be accurate, only if it separates
very well. Hence the desired resolution is at least 3.0.for reversed phase liquid chromatographic method development of fingolimod
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Figure 5 Chromatogram obtained with DoE optimized mobile phase and column temperature (Section 2.1.4) in the predefined gradient
program (T/A:B: 0/70:30, 60/30:70). The chromatogram is sliced into two. Slice A represents the critical phase (T/A:B: 0/70:30, 30/50:50);
where the gradient program is not to be changed. Modification of gradient program shall be done in slice B. Mobile phase A:B ratio with
respect to time is given in the x-axis.
Figure 6 Chromatogram obtained with finalized method conditions (refer Section 2.1.3) for related substances. Critical separation is
shown in zoom.
8 R. Suresh Kumar et al.Derringer’s desirability function (Parajo et al., 1992) was
used to optimize the method for three responses with three dif-
ferent targets. Weights equal to 1 was given for all three
responses. Highly desirable regions (Desirability = 1.0) were
examined to select the point for normal operation. Contour
plot of desirability and design space is given in Fig. 3. From
the design space, components of the mobile phase were chosen
as 3 mM TBAHS in 0.02% oPA and the column temperature
as 60 C.
3.1.7. Retention window
To verify that whether the predefined gradient program is a
hidden factor in influencing the response, the responses mea-Please cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:sured are viewed through a RT window (RTW) (Fig. 4); a plot
of retention time versus responses studied. Observation of
increasing or decreasing trend of responses with respect to
RT will be a clear indication of influence of gradient program.
From Fig. 4 it was understood that the responses are not
arranged in a linear fashion and no correlation exists between
RT and responses. High and low responses are observed
within one minute window. For example, in the window of
24–25 min the tailing factor ranges from 0.74 to 3.88
(RTW2). In the window of 25 to 26 min resolution between
imp-3 and imp-4 is in the range of 0–1.34 (RTW1) and resolu-
tion between FIM and imp-3 ranges from 1.64 to 3.16
(RTW3). Each run experiences same ratio of aqueous andfor reversed phase liquid chromatographic method development of fingolimod
//dx.doi.org/10.1016/j.arabjc.2015.08.012
Figure 7 Chromatogram obtained with finalized method condi-
tions (refer Section 2.1.4) for assay.
Reversed phase liquid chromatographic method development of fingolimod hydrochloride 9organic mobile phases at a particular RT and hence the varia-
tion observed in the responses is concluded as predominant
effect of factors studied.
3.1.8. Modification of gradient program
With optimized mobile phase and column temperature, a solu-
tion of FIM spiked with impurities was injected in the prede-
fined gradient program (T: %A/B – 0: 70/30, 60: 30/70).
From Fig. 5 it was evident that all the impurities except
impurity 7 were eluted before 30 min (slice A) and impurity
7 was eluted at the edge of the gradient program (slice B). Fur-
ther it was understood that this gradient program is not suffi-
cient enough to elute highly non-polar impurities, which may
found in crude or degraded samples.
As the method was optimized for critical separation, it is
important to modify the gradient without disturbing DoE out-
come. Hence it was decided to maintain the same ramp of the
gradient for 30 min and modifying the program after 30 min.
%B at 30 minutes ¼ Iþ ðR 30Þ ð2Þ
where I= initial mobile phase B%= 30% and R= ramp.
R ¼ ð%B at Final
%B at initialÞ=Time of the gradient run ð3Þ
Here, the calculated R is 0.66 and %B at 30 min is 50. The
calculated ramp is represented in Fig. 5 at every 15 min inter-
vals. The gradient program was modified for the run after
30 min, with few trials. A chromatogram obtained with the
modified gradient program (finalized method conditions, referTable 6 Mass balance study.
Degradation conditions Total impurities (%
As such sample 0.10
Water hydrolysis (Reflux, 48 h) 0.11
Thermal degradation (90 C, 10 days) 0.10
Photo degradation (as per ICH) 0.10
Acid degradation (2 M HCl, 70 C, 48 h) 0.34
Base degradation (0.5 M NaOH, RT, 48 h) 11.60
Peroxide degradation (3% H2O2, 48 h) 4.40
Please cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:Section 2.1.4) is given in Fig. 6. Finalized method ensured the
elution of imp-7 quickly and secured the place for elution of
highly non-polar impurities.
A rapid gradient program was proposed for assay method
and ensured that no peak is left merged with FIM. Sample
concentration for assay analysis is twenty times less than
related substances analysis and hence the observed tailing fac-
tor is around 1.1. Assay method chromatogram of sample
spiked with impurities is given in Fig. 7.
3.1.9. Specificity & mass balance study
Forced degradation was conducted on FIM sample to ensure
the specificity of the method. Each degraded sample was
injected in both related substances program and assay pro-
gram. Condition adopted for degradation and the mass bal-
ance is tabulated in Table 6.
From Table 6 it is evident that FIM is very stable with
respect to temperature, light (ICH Q1B, 1996) and water
hydrolysis and almost stable to acid hydrolysis. The molecule
is sensitive to base hydrolysis and oxidation. Proposed degra-
dation pathway is given in Fig. 8.
A mixture of methanol: water (8:2, v/v) was used for base
degradation, as the molecule was getting precipitated when
using diluent as per method condition (water:acetonitrile,
30:70). The major impurity observed at the RRT 1.25 in the
base degraded sample was subjected to LCMS analysis. m/z
of the impurity was found to be 350.4. Reaction of aralkyl
amine with carbon dioxide (CO2) is well known (Wright and
Moore, 1948). On treating with sodium hydroxide (NaOH),
the HCl (counter ion of fingolimod base) was getting neutral-
ized and the free amine was readily available for reaction with
CO2 and forms carbamate anion (Jackson et al., 2011). Forma-
tion of carbamate anion is possible even with atmospheric CO2
(Wright and Moore, 1948) and it was observed in this study.
Based on this, structure hitherto possible and Mass spectra
are given in Fig. 9. Two major impurities formed in peroxide
degraded sample were identified by LCMS analysis. m/z [M
+ H]+ of the impurities were 340.2 and 322.0. Formation of
unstable hydro peroxide and ketones is possible during oxida-
tion of alkyl aromatics (Rao and Awasthi, 2007) and in general
benzylic protons are highly reactive (Morrison and Boyd,
1992). Based on these two facts structure hitherto possible
are proposed in Fig. 9 along with their mass spectra.
The FIM samples analyzed did not have the base degraded
impurity and oxidized impurities. Further, under accelerated
stability conditions (40 ± 2 C, 75 ± 5% RH for 6 months)
the molecule is very stable and no degradation impurity is
observed. Hence further attempts were not given for isolation
or characterization of these degradants. Mass balance close tow/w) Assay (% w/w) Mass balance (%w/w)
99.5 99.6
99.7 99.8
99.5 99.6
99.8 99.9
99.4 99.7
87.0 98.6
94.5 98.9
for reversed phase liquid chromatographic method development of fingolimod
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Figure 8 Proposed degradation pathway for oxidation and base degradation.
10 R. Suresh Kumar et al.99% (Table 6) shows the stability indicating power of the
method. Homogeneity of the FIM peak was ensured with
Photo Diode Array detector.
3.1.10. Chromatographic conditions for UHPLC
Mobile phase (3 mM TBAHS in 0.02% oPA) and column tem-
perature (60 C) as optimized through DoE were used for
UHPLC method. The HPLC parameters used for DoE study:
Gradient program (T/%A:%B: 0/70:30, 60/30:70), flow rate
(1.0 ml/min) and injection volume (10 ll) were scaled to oper-
ate the method in UHPLC system. The elution was carried out
in a BEH-C18 column (Waters). The dimension of the
UHPLC column and formula used for scaling the method to
UHPLC is given in Table 7.
A chromatogram obtained with UHPLC method is given in
Fig. 10, which is much resembled to HPLC chromatogram ofPlease cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:Fig. 5. Interested UHPLC users can further modify the gradi-
ent program as described in Section 3.1.8.
3.2. Validation
3.2.1. Precision
The % RSD for the content of impurities is within 2% for each
specified impurity during repeatability and intermediate preci-
sion studies. % RSD for assay content during repeatability
and intermediate precision studies is <0.4% for drug sub-
stance and <1.0% for drug product. The result indicates that
method is precise.
3.2.2. Limit of detection & limit of quantification
LOD for Imp-1, 2, 3, 4, 5, 6, 7 and FIM is 0.005%,
0.004%, 0.005%, 0.005%, 0.005%, 0.005%, 0.005%,for reversed phase liquid chromatographic method development of fingolimod
//dx.doi.org/10.1016/j.arabjc.2015.08.012
Figure 9 Mass spectra and chromatograms of base & oxidation degradation. A – Mass spectra and a possible structure of the impurity
(carbamate anion of FIM). B – Chromatogram of base degradation. C – Mass spectra of oxidation degradation product-1. D – Mass
spectra of oxidation degradation product-2. E – Chromatogram of oxidation degradation. (For LC-MS condition refer Section 2.1.6).
Reversed phase liquid chromatographic method development of fingolimod hydrochloride 110.003% and 0.004% respectively. LOQ for Imp-1, 2, 3,
4, 5, 6, 7 and FIM is 0.020%, 0.016%, 0.021%,
0.020%, 0.020%, 0.021%, 0.012% and 0.016% respec-
tively. The LOD, LOQ values are with respect to samplePlease cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:concentration of 1.4 mg/ml and injection volume of 10 ll
% RSD for the area at LOQ level is below 10% for all
impurities. Recovery for impurities ranges from 89% to
96%.for reversed phase liquid chromatographic method development of fingolimod
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Table 7 Optimization of the method for UHPLC.
HPLC1 UHPLC2
Parameters
Column length (mm) (L) 150 50
Column internal diameter (mm) (dc) 4.6 2.1
Column particle size (lm) (dp) 3.5 1.7
Column volume (Cv) 2.49 0.17
Void volume (V0) 1.69 0.12
Chromatographic conditions
Injection volume (ll) (Vi) 10 0.69
Flow rate (ml/min) (F) 1 0.43
Gradient time (min) (tg) for 60 9.9
%B 30–70
Formulae used for conversion to UHPLC
Cv = L  P  (dc/2)2  1/1000 V0 = Cv  68/100
Vi2 = Vi1  (dc22  L2/dc12  L1) F2 = F1  (dc22/dc12)  (dp1/dp2)
tg2 = tg1  (V02/V01)  (F1/F2)
Figure 10 Chromatogram obtained with UHPLC. Flow rate: 0.44 ml/min, Injection volume: 0.7 ll, Gradient program: T/A/B: 0/70/30,
10/30/70. For mobile phase and other chromatographic conditions refer Section 2.1.4.
12 R. Suresh Kumar et al.3.2.3. Linearity
The correlation coefficient and coefficient of determination (r2)
for impurities and FIM is P0.999. In related substances
method, % Y-intercept value for each impurity or FIM is
within ±3% of response at 100% concentration level. For
assay, the correlation coefficient and r2 of FIM is 0.999 and
% Y-intercept value is 0.3% of response at 100% concentra-
tion level. To assess the appropriateness of using a linear
regression model to fit the data, residual plots were produced.
The points in these plots were randomly distributed around the
horizontal zero axis suggesting that the linear model gives a
good fit of the data.
3.2.4. Accuracy
Individual and average recovery in three preparations and at
three concentrations for impurities is within 100 ± 10%. For
assay of FIM the recovery is within 100 ± 0.5% for drug sub-
stance and within 100 ± 2% for drug product.
3.2.5. Robustness
Design space (Fig. 3) of the method indicates robustness in
terms of column temperature, and concentration of mobile
additives (TBAHS and oPA). Mobile phase flow rate, whichPlease cite this article in press as: Suresh Kumar, R. et al., A systematic approach
hydrochloride via design augmentation. Arabian Journal of Chemistry (2015), http:is another parameter normally performed during robustness
checking (ICH Q2(R1), 2005) was also studied at ±0.2 ml/
min and ensured that the system meets the suitability criteria
(Table 5).
4. Conclusion
A stability indicating method was developed for FIM drug
substances by using DoE. The CCD was reached via augment-
ing a full factorial design with the intention of reducing the
number of runs, if possible. We have demonstrated to use
RT window as a verification tool, while executing a DoE in
a fixed gradient program. RT window used in this study was
a logical interpretation based on general behavior of com-
pounds in a reversed phase chromatography. The method is
specific for the quantification of FIM and its related com-
pounds including degradation products. The developed
method is robust, reliable and highly sensitive in detection,
user friendly and can be used for quality control and stability
studies of FIM. Assay of FIM can be executed in the same
chromatographic system of related substances with a short
run time method. In this study, scaling a systematically devel-
oped robust HPLC method to UHPLC appears as simple task.for reversed phase liquid chromatographic method development of fingolimod
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